Insider · CIK 0001828131

O'Kane Kieran

Reports to the SEC for 1 company · LOUISVILLE, CO

sec.gov

Transactions

Companies

Filings

CIK

0001828131

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-23	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−535 sh	$12.78	−$6,834.946	9,819
2026-02-20	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,469 sh	—	—	4,406
2026-02-20	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,469 sh	—	—	10,354
2026-02-10	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−584 sh	$10.08	−$5,889.114	8,885
2026-02-09	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,600 sh	—	—	9,469
2026-02-09	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,527 sh	—	—	1,526
2026-02-09	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−73 sh	—	—	0
2026-01-16	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−298 sh	$8.15	−$2,428.491	7,869
2026-01-15	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+805 sh	—	—	8,167
2026-01-15	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−805 sh	—	—	1,609
2026-01-02	BDSXBIODESIX INC · Stock Options (Right to Buy)A Award	Chief Commercial Officer	AAward	+27K sh	—	—	27,000
2025-11-10	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−25 sh	$7.62	−$190.5	7,362
2025-11-10	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+75 sh	—	—	7,387
2025-11-10	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−75 sh	—	—	73
2025-08-13	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−476 sh	$0.42	−$198.159	140,065
2025-08-12	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,489 sh	—	—	2,979
2025-08-12	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,489 sh	—	—	140,541
2025-05-13	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−238 sh	$0.35	−$83.99	139,052
2025-05-12	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−239 sh	$0.36	−$85.897	139,290
2025-05-09	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,490 sh	—	—	4,468
2025-05-09	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,490 sh	—	—	139,529
2025-02-20	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+118K sh	—	—	117,500
2025-02-20	BDSXBIODESIX INC · Stock Options (Right to buy)A Award	Chief Commercial Officer	AAward	+235K sh	—	—	235,000
2025-02-20	BDSXBIODESIX INC · Stock Options (Right to buy)A Award	Chief Commercial Officer	AAward	+87.3K sh	—	—	87,319
2025-02-11	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−17.5K sh	$0.92	−$16.2K	128,039
2025-02-10	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−30.5K sh	—	—	61,067
2025-02-10	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+48.1K sh	—	—	145,566
2025-02-10	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,489 sh	—	—	5,958
2025-02-10	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−16.1K sh	—	—	48,286
2024-11-12	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−224 sh	$1.40	−$313.779	97,448
2024-11-11	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−238 sh	$1.39	−$331.034	97,672
2024-11-08	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,490 sh	—	—	97,910
2024-11-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,490 sh	—	—	7,447
2024-08-12	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−120 sh	$1.57	−$188.628	89,628
2024-08-09	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−345 sh	$1.60	−$552.345	89,748
2024-08-08	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,489 sh	—	—	90,093
2024-08-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,489 sh	—	—	8,937
2024-05-23	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+13.1K sh	—	—	88,604
2024-05-23	BDSXBIODESIX INC · Series A Non-Voting Convertible Preferred StockM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−327 sh	—	—	0
2024-05-09	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−468 sh	$1.48	−$692.406	75,524
2024-05-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,489 sh	—	—	10,426
2024-05-08	BDSXBIODESIX INCM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	+1,489 sh	—	—	75,992
2024-04-05	BDSXBIODESIX INC · Series A Non-Voting Convertible Preferred StockA Award	Chief Commercial Officer	AAward	+327 sh	$46.00	+$15K	327
2024-02-21	BDSXBIODESIX INC · Stock Options (Right to buy)A Award	Chief Commercial Officer	AAward	+35.3K sh	—	—	35,307
2024-02-12	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−5,412 sh	$1.66	−$9,009.356	68,005
2024-02-09	BDSXBIODESIX INCS Sale	Chief Commercial Officer	SSale	−6,319 sh	$1.92	−$12.1K	73,417
2024-02-08	BDSXBIODESIX INC · Stock Options (Right to buy)A Award	Chief Commercial Officer	AAward	+129K sh	—	—	128,761
2024-02-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−1,490 sh	—	—	11,915
2024-02-08	BDSXBIODESIX INC · Restricted Stock UnitsM Exercise/Conversion	Chief Commercial Officer	MExercise/Conversion	−30.5K sh	—	—	91,601
2024-02-08	BDSXBIODESIX INC · Restricted Stock UnitsA Award	Chief Commercial Officer	AAward	+64.4K sh	—	—	64,381

Recent filings

Accepted (ET)
Feb 234
O'Kane Kieran0000905148-26-000986
SEC(opens sec.gov)
Feb 114
O'Kane Kieran0000905148-26-000635
SEC(opens sec.gov)
Jan 204
O'Kane Kieran0000905148-26-000251
SEC(opens sec.gov)
Jan 64
O'Kane Kieran0000905148-26-000067
SEC(opens sec.gov)
Nov 134
O'Kane Kieran0000905148-25-003931
SEC(opens sec.gov)
Aug 144
O'Kane Kieran0000905148-25-002982
SEC(opens sec.gov)
May 134
O'Kane Kieran0000905148-25-001607
SEC(opens sec.gov)

Companies

BIODESIX INCChief Commercial OfficerBDSX

Address

919 WEST DILLON RD

LOUISVILLE, CO, 80027